Patents by Inventor Enrique Escandon

Enrique Escandon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apo-2L receptor agonist and CPT-11 synergism
    Publication number: 20110059104
    Abstract: Methods of using effective amounts of Apo-2L receptor agonists and CPT-11 to induce apoptosis and suppress growth of cancer cells are provided.
    Type: Application
    Filed: July 29, 2010
    Publication date: March 10, 2011
    Applicant: Genentech, Inc.
    Inventors: Enrique Escandon, Sean K. Kelley, Hong Xiang, Judith A. Fox
  • APO-2L receptor agonist and CPT-11 synergism
    Publication number: 20090169569
    Abstract: Methods of using effective amounts of Apo-2L receptor agonists and CPT-11 to induce apoptosis and suppress growth of cancer cells are provided.
    Type: Application
    Filed: September 12, 2008
    Publication date: July 2, 2009
    Applicant: Genentech, Inc.
    Inventors: Enrique Escandon, Sean K. Kelley, Hong Xiang, Judith A. Fox
  • Apo-2l receptor agonist and cpt-11 synergism
    Publication number: 20040005314
    Abstract: Methods of using effective amounts of Apo-2L receptor agonists and CPT-11 to induce apoptosis and suppress growth of cancer cells are provided.
    Type: Application
    Filed: January 23, 2003
    Publication date: January 8, 2004
    Inventors: Enrique Escandon, Sean K Kelley, Hong Xiang, Judith A Fox